Skip to main content
Karilyn Larkin, MD, Hematology, Columbus, OH, Ohio State University Wexner Medical Center

KarilynTheresamelaLarkinMD(She/Her)

Hematology • Columbus, OH

Hematologic Oncology

Assistant Professor of Internal Medicine, Division of Hematology

Join to view full profile

Dr. Larkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Larkin's full profile

Already have an account?

Summary

  • Dr. Karilyn Larkin is a hematologist in Columbus, OH and is affiliated with multiple hospitals in the area, including Ohio State University Wexner Medical Center and James Cancer Hospital and Solove Research Institute. She received her medical degree from Albany Medical College and has been in practice 7 years. She specializes in hematologic oncology.

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Ohio State University Hospital
    Ohio State University HospitalResidency, Internal Medicine, 2010 - 2013
  • Albany Medical College
    Albany Medical CollegeClass of 2010

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2010 - 2024
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • MicroRNA-29b mediates altered innate immune development in acute leukemia.  
    Mundy-Bosse BL, Scoville SD, Chen L, McConnell K, Mao HC, Ahmed EH, Zorko N, Harvey S, Cole J, Zhang X, Costinean S, Croce CM, Larkin K, Byrd JC, Vasu S, Blum W, Yu J,..., JCI, 10/24/2016
  • Targeting BTK through microRNA in chronic lymphocytic leukemia.  
    Bottoni A, Rizzotto L, Lai TH, Liu C, Smith LL, Mantel R, Reiff S, El-Gamal D, Larkin K, Johnson AJ, Lapalombella R, Lehman A, Plunkett W, Byrd JC, Blachly JS, Woyach ..., Blood, 10/17/2016

Abstracts/Posters

  • Effect of Early Post Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
    Karilyn Larkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • NPM1 mutations Using Deep Amplicon Sequencing and Broad Next Generation Sequencing at the Time of Complete Remission Is Informative to Predicting Risk of Relapse Follo...
    Karilyn Larkin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • An Aggressive Leukemia Is More Lethal for Black Patients
    An Aggressive Leukemia Is More Lethal for Black PatientsJuly 7th, 2022
  • Young Black People with This Type of Leukemia Have Worse Outcomes
    Young Black People with This Type of Leukemia Have Worse OutcomesJuly 7th, 2022
  • Young Black Patients with AML Have Significantly Worse Outcomes Than White Patients of Same Age
    Young Black Patients with AML Have Significantly Worse Outcomes Than White Patients of Same AgeJuly 5th, 2022
  • Join now to see all

Hospital Affiliations

Dr. Karilyn Larkin, Dr. Karilyn Larkin, MD, Dr. K Larkin, Dr. Karilyn Theresamela Larkin